| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/14/2002 | CN1088992C Topically administrable compositions containing 2-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432934 Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | CA2167524C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 08/08/2002 | WO2002060868A2 Inhibitors of prenyl-protein transferase |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060856A1 Novel quaternary ammonium salt compounds, process for producing the same and use thereof |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060486A2 Controlled release microsphere system for administration of drug to the eye |
| 08/08/2002 | WO2002060473A2 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | WO2002060451A1 Method of treating certain eye diseases |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002011747A3 Transglutaminase for inhibiting angiogenesis |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001010406A3 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107240 N-substituted glycine derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107238 Topical antibiotic composition for treatment of eye infection |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106365 For therapy of diseases which can be treated or alleviated by a stimulation of the production of cytokines, particularly of IL-12 |
| 08/08/2002 | US20020106304 Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436748A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436397A1 Method of treating certain eye diseases |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | CA2426684A1 Inhibitors of prenyl-protein transferase |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1228784A2 Preparation for veterinary use |
| 08/07/2002 | EP1228767A1 Use of beta-Glucuronidase for the treatment of immune or allergic diseases |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228058A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228032A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |